Guj HC: Depression can be classified as serious illness

Ahmedabad (PTI) Depression can be classified as a serious illness, especially in the context of the COVID-19 pandemic, the Gujarat High Court has observed, while setting aside the cancellation of registration and admission of an engineering student by a government college for not appearing for requisite exams due to depression and suicidal thoughts.

The court issued the order on August 31 and a copy of it was made available on Thursday.

The academic performance review committee of the Surat-based Sardar Vallabhbhai National Institute of Technology (SVNIT) in October 2020 cancelled the registration and admission of the first-year B Tech (Bachelor of Technology) student, for not earning 25 credits needed for getting promoted to the next semester.

The student challenged this in the HC on the ground that he had suffered from “severe depressive episodes with suicidal ideation“, which started in January 2020 and peaked in May-June last year due to the COVID-19 pandemic situation, which is why he could not appear for the examination.

“In the facts and circumstances of the case and more particularly in the context of the currency of the pandemic period, the depressive state of mind and the depression created in the petitioner student, can be classified as serious illness,” the court of Justice N V Anjaria observed.

The depressive cycle which the petitioner suffered was during the period of COVID-19 pandemic itself. It was a period of wide-spread despondency, the court noted. PTI

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise